Literature DB >> 19721789

Chemotherapy: managing side effects and safe handling.

Valerie MacDonald1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19721789      PMCID： PMC2684058     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  3 in total

1.  Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.

Authors: 
Journal:  Vet Comp Oncol       Date:  2004-12       Impact factor: 2.613

2.  Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study.

Authors:  J D Chretin; K M Rassnick; N A Shaw; K A Hahn; G K Ogilvie; O Kristal; N C Northrup; A S Moore
Journal:  J Vet Intern Med       Date:  2007 Jan-Feb       Impact factor: 3.333

Review 3.  Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials.

Authors:  M D van de Wetering; M A de Witte; L C M Kremer; M Offringa; R J P M Scholten; H N Caron
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162
  3 in total
  21 in total

1.  Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

Authors:  Kristin S Kicenuik; Nicole C Northrup; Dawn M Clarke; Lisa J Bazzle
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

Review 2.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

3.  Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents.

Authors:  Wei Chen; Teresa Seefeldt; Alan Young; Xiaoying Zhang; Xiangming Guan
Journal:  Bioorg Med Chem       Date:  2010-11-13       Impact factor: 3.641

4.  Assessment of neutrophil function in canine cancer patients undergoing chemotherapy and correlation with neutrophil numbers.

Authors:  Arefeh Ravanbakhsh; Khawaja Ashfaque Ahmed; Valerie MacDonald-Dickinson; Nicole J Fernandez; Melissa D Meachem; Ryan M Dickinson
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

5.  Achievability to Extract Specific Date Information for Cancer Research.

Authors:  Liwei Wang; Jason Wampfler; Angela Dispenzieri; Hua Xu; Ping Yang; Hongfang Liu
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

6.  Novel Silver-Platinum Nanoparticles for Anticancer and Antimicrobial Applications.

Authors:  Aida López Ruiz; Caterina Bartomeu Garcia; Sandra Navarro Gallón; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2020-01-15

7.  Derivation of feline vaccine-associated fibrosarcoma cell line and its growth on chick embryo chorioallantoic membrane - a new in vivo model for veterinary oncological studies.

Authors:  K Zabielska; R Lechowski; M Król; K M Pawłowski; T Motyl; I Dolka; A Zbikowski
Journal:  Vet Res Commun       Date:  2012-08-15       Impact factor: 2.459

8.  Targeting Membrane Lipid a Potential Cancer Cure?

Authors:  Loh Teng-Hern Tan; Kok-Gan Chan; Priyia Pusparajah; Wai-Leng Lee; Lay-Hong Chuah; Tahir Mehmood Khan; Learn-Han Lee; Bey-Hing Goh
Journal:  Front Pharmacol       Date:  2017-01-23       Impact factor: 5.810

9.  Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies.

Authors:  Anna Małek; Bartłomiej Taciak; Katarzyna Sobczak; Agnieszka Grzelak; Michał Wójcik; Józef Mieczkowski; Roman Lechowski; Katarzyna A Zabielska-Koczywąs
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

10.  Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.

Authors:  Meng-Chuan Chen; Yen-Lin Chen; Chi-Feng Lee; Chih-Huang Hung; Tz-Chong Chou
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.